Biocodex, Inc.
$25.0K 333 recipients
Compare payment profiles
CMS Open Payments · Program Year 2024
CIVCO Medical Instruments
CIVCO Medical Instruments reported $24,995.07 across General Payments, Research, and Ownership to 395 physicians and teaching hospitals across 395 transactions.
- $25.0K Below-median payer
- All-tracks total
- 395 Above-median volume
- Transactions
- 395 Above-median reach
- Recipients
- −$593.52
- General Payments vs PY2023
CIVCO Medical Instruments reported $24,995.07 across all CMS Open Payments tracks (General + Research + Ownership) to 395 physicians and teaching hospitals in Program Year 2024 - ranking #1495 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $24,995.07, averaging $63.28 per recipient.
CIVCO Medical Instruments's payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
F
25/100
Total payments
F
10/100
Transaction volume
F
13/100
Physician reach
F
13/100
Payment type diversity
D
63/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer civco-medical-instruments CIVCO Medical Instruments
$25.0K · #1495/1,925 · 0.0% industry · PY2024
- TOT $25.0K
- RANK #1495
- SHARE 0.0%
- TXN 395
- RCP 395
- CAT 5
- GEN $25.0K
- ΔGEN −$593.52
- TOP1 13.6%
- PY 2024
Volume peers
Nearest volume peer: Biocodex, Inc. ($25.0K)
CIVCO Medical Instruments sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
CIVCO Medical Instruments's CMS-reported General Payments decreased by $593.52 (−2.3%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: CIVCO MEDICAL INSTRUMENTSPY2023: CIVCO MEDICAL INSTRUMENTSPY2024: CIVCO Medical Instruments. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $25,588.59
- PY2024
- $24,995.07
What the Data Shows for CIVCO Medical Instruments
Three separate CMS disclosure tracks feed the all-tracks total above - General, Research, and Ownership/Investment - each reported under its own rules and combined here for one comparable figure. For CIVCO Medical Instruments that figure is drawn almost entirely from the General Payments track (day-to-day consulting, meals, travel and speaking fees). CMS releases each Program Year roughly 12 months after it ends; the methodology page covers the full standardization basis.
Of the 5 general-payment categories charted below, "Food and Beverage" is the largest at $8.5K across 377 transactions, 34.2% of this company's General Payments (see our methodology for how research and ownership payments are reported separately).
General Payment Breakdown by Type
"Food and Beverage" leads CIVCO Medical Instruments's 5-category general-payment breakdown at $8.5K, 34.2% of the reported total.
CIVCO Medical Instruments reports 5 general-payment categories - the top three are Food and Beverage (34.2%), Education (33.3%), and Honoraria (12.0%). The remaining 2 categories make up 20.5% of this company's reported general-payment total. That multi-category mix is the kind of profile single-category reporters cannot show.
How CIVCO Medical Instruments divides its payments
How the reported total splits across payment categories
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Food and Beverage | $8.5K | 377 | 34.2% |
| Education | $8.3K | 4 | 33.3% |
| Honoraria | $3.0K | 10 | 12.0% |
| Consulting Fee | $2.6K | 3 | 10.5% |
| Compensation for Services Other Than Consulting | $2.5K | 1 | 10.0% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $12,704.00 (50.8%) of $24,995.07 in this company's General Payments records across 368 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for CIVCO Medical Instruments
The five named recipients with the highest reported General Payments from this company
- 1
Lee Pressler
$3,387.00 across 1 reported transactions
- 2
Amit Patel
$3,192.00 across 1 reported transactions
- 3
Todd Sexton
$2,625.00 across 3 reported transactions
- 4
Ahmed Ghazi
$2,500.00 across 1 reported transactions
- 5
Craig Rogers
$1,000.00 across 1 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
CIVCO Medical Instruments's spend rank (#1495 of 1,925, bottom 22% by spend) and concentration rank (#1,232 of 1,838, bottom 33% least concentrated) land at roughly the same percentile, an unusually proportionate case where payment size and payment concentration move together.
View all 12 companies in this HHI neighborhood as a list
- Acteon Inc : $79.3K total payments, HHI 621
- Smaio USA Corporation : $12.2K total payments, HHI 619
- Sanofi US Services Inc. : $1.2M total payments, HHI 618
- LKC Technologies, Inc. : $275.7K total payments, HHI 614
- Volta Medical Inc : $220.2K total payments, HHI 613
- Rivanna Medical, Inc : $51.3K total payments, HHI 604
- CIVCO Medical Instruments (this company) : $25.0K total payments, HHI 601
- Rapid Medical Ltd : $271.8K total payments, HHI 600
- Getinge USA Sales, LLC : $462.9K total payments, HHI 589
- Henry Schein One, LLC : $39.9K total payments, HHI 589
- Nsk America Corporation : $1.2K total payments, HHI 588
- Merck KGaA : $285.7K total payments, HHI 587
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as CIVCO Medical Instruments's, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about CIVCO Medical Instruments.
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with CIVCO Medical Instruments.
Showing 6 of 1,924 companies with CMS-reported payment data.
Aucta Pharmaceuticals, Inc.
$25.2K 1,636 recipients
Compare payment profiles
Topcon Corporation
$25.2K 11 recipients
Compare payment profiles
Forthright Medical-AZ, LLC
$24.7K 251 recipients
Compare payment profiles
Piedmont Plus Innovation
$24.7K 250 recipients
Compare payment profiles
Sc Medica
$25.3K 17 recipients
Compare payment profiles
Put this to use
CIVCO Medical Instruments ranks #1495 of 1,925 by all-tracks total payments, led by "Food and Beverage".
- See how manufacturer spending compares across the full leaderboard. Top 100 by total payments
- Compare "Food and Beverage" spend across every manufacturer, not just CIVCO Medical Instruments. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.